...
首页> 外文期刊>Journal of Nippon Medical School >Current Practice and Outcomes of Peritoneal Dialysis in the Nippon Medical School Musashi Kosugi Hospital
【24h】

Current Practice and Outcomes of Peritoneal Dialysis in the Nippon Medical School Musashi Kosugi Hospital

机译:日本医学院武藏小杉医院的腹膜透析现状与结果

获取原文
           

摘要

Introduction: Various innovations for preventing complications and improving a patient's quality of life have been implemented for peritoneal dialysis (PD), which was established in Japan approximately 35 years ago and introduced at our hospital in 1999. Herein, we investigate the outcomes of patients undergoing PD to identify approaches for improving their long-term prognosis. Methods: This retrospective study included 114 patients who underwent PD between September 1999 and August 2017 and included various parameters such as patient survival rate, technical survival rate, cause (s) of PD withdrawal, incidence of peritonitis, dialysis duration, and change in residual renal function (RRF). Furthermore, factors associated with PD withdrawal and duration, as well as risk factors for peritonitis, were examined. Results: Mean (± standard deviation) PD duration was 35.62 (±29.88) months in all patients and 37.16 (±34.09) months in 58 patients who withdrew from treatment. Five-year continuance and survival rates were 40.41% and 55.74%, respectively (p=0.0061). However, in patients aged ≥65 years, the continuance and survival rates were not significantly different (p=0.1250). Furthermore, the continuance and survival rates in diabetic patients were not significantly different from those of non-diabetic patients (p=0.1334 and 0.7140, respectively). Comparison of changes in RRF in young and elderly patients revealed that it was not significantly sustained in elderly patients (p=0.0259). The Cox proportional hazards model revealed that age (p=0.0455) and total cholesterol levels (p=0.0494) were independent risk factors for PD withdrawal, and multiple regression analysis showed that the presence of peritonitis (p=0.0063) and low-density lipoprotein cholesterol (LDL-C) levels (p=0.0087) were significant factors for PD duration. Peritonitis incidence was 0.077 times per patient per year, and multivariate analysis identified PD duration (p=0.0009) and LDL-C levels (p=0.0054) as independent risk factors for peritonitis. Conclusion: The findings of this study revealed that assessment of the nutritional status of the patient and prevention of peritonitis are important for continuation of PD. PD is a safe treatment option that can maintain the quality of life in elderly patients. In a rapidly aging society, the need for PD-based medical care is expected to increase.
机译:简介:大约35年前在日本成立并于1999年在我们医院引入的腹膜透析(PD)已实施了各种预防并发症和改善患者生活质量的创新措施。在此,我们研究了接受腹膜透析的患者的结局。 PD确定改善其长期预后的方法。方法:这项回顾性研究纳入了114名在1999年9月至2017年8月期间接受PD治疗的患者,并纳入了各种参数,例如患者存活率,技术存活率,PD停药原因,腹膜炎的发生率,透析持续时间和残留改变肾功能(RRF)。此外,检查了与PD停药和持续时间相关的因素以及腹膜炎的危险因素。结果:所有患者的平均PD持续时间为35.62(±29.88)个月,退出治疗的58例患者为37.16(±34.09)个月。五年连续率和生存率分别为40.41%和55.74%(p = 0.0061)。但是,对于≥65岁的患者,持续性和生存率没有显着差异(p = 0.1250)。此外,糖尿病患者的持续性和生存率与非糖尿病患者没有显着性差异(分别为p = 0.1334和0.7140)。比较年轻患者和老年患者的RRF变化,发现老年患者RRF并未显着持续(p = 0.0259)。 Cox比例风险模型显示年龄(p = 0.0455)和总胆固醇水平(p = 0.0494)是PD停药的独立危险因素,并且多元回归分析表明存在腹膜炎(p = 0.0063)和低密度脂蛋白胆固醇(LDL-C)水平(p = 0.0087)是PD病程的重要因素。腹膜炎的发生率为每名患者每年0.077次,多因素分析确定PD持续时间(p = 0.0009)和LDL-C水平(p = 0.0054)是腹膜炎的独立危险因素。结论:这项研究的结果表明,评估患者的营养状况和预防腹膜炎对于继续PD至关重要。 PD是一种安全的治疗选择,可以维持老年患者的生活质量。在迅速老龄化的社会中,对基于PD的医疗服务的需求预计会增加。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号